Novel synthesised flavone derivatives provide significant insight into the structural features required for enhanced anti-proliferative activity. Issue 69 (8th July 2016)

• Record Type: Journal Article
• Authors: Ravishankar, Divyashree; Watson, Kimberly A.; Greco, Francesca; Osborn, Helen M. I.
• Is Part Of: RSC advances. Volume 6:Issue 69(2016)
• Page Start: 64544
• Page End: 64556
• Publication Date: 2016-07-08
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/c6ra11041j
• Languages: English
• ISSNs: 2046-2069

Abstract

Abstract : Synthesis and antiproliferative evaluation of a library of 76 methoxy and hydroxy flavones, and their 4-thio analogues showed that the novel thioflavones15f and16f exhibit 7–46 fold greater anti-proliferative potency than the natural flavone chrysin (2d ). Abstract : With many cancers showing resistance to current chemotherapies, the search for novel anti-cancer agents is attracting considerable attention. Natural flavonoids have been identified as useful leads in such programmes. However, since an in-depth understanding of the structural requirements for optimum activity is generally lacking, further research is required before the full potential of flavonoids as anti-proliferative agents can be realised. Herein a broad library of 76 methoxy and hydroxy flavones, and their 4-thio analogues, was constructed and their structure–activity relationships for anti-proliferative activity against the breast cancer cell lines MCF-7 (ER +ve), MCF-7/DX (ER +ve, anthracycline resistant) and MDA-MB-231 (ER −ve) were probed. Within this library, 42 compounds were novel, and all compounds were afforded in good yields and >95% purity. The most promising lead compounds, specifically the novel hydroxy 4-thioflavones15f and16f, were further evaluated for their anti-proliferative activities against a broader range of cancer cell lines by the National Cancer Institute (NCI), USA and displayed significant growth inhibition profiles ( e.g. compound-15f : MCF-7 (GI50 = 0.18 μM), T-47D (GI50 = 0.03 μM) and MDA-MB-468 (GI50 = 0.47 μM) and compound-16f : MCF-7 (GI50 = 1.46 μM), T-47D (GI50 = 1.27 μM) and MDA-MB-231 (GI50 = 1.81 μM)). Overall, 15f and16f exhibited 7–46 fold greater anti-proliferative potency than the natural flavone chrysin (2d ). A systematic structure–activity relationship study against the breast cancer cell lines highlighted that free hydroxyl groups and the B-ring phenyl groups were essential for enhanced anti-proliferative activities. Substitution of the 4-CO functionality with a 4-CS functionality, and incorporation of electron withdrawing groups at C-4′ of the B-ring phenyl, also enhanced activity. Molecular docking and mechanistic studies suggest that the anti-proliferative effects of flavones15f and16f are mediated via ER-independent cleavage of PARP and downregulation of GSK-3β for MCF-7 and MCF-7/DX cell lines. For the MDA-MB-231 cell line, restoration of the wild-type p53 DNA binding activity of mutant p53 tumour suppressor gene was indicated.